Is it time to try or to trial statins to prevent recurrent venous thromboembolism?
J Thromb Haemost. 2014 May 20;
Authors: Rodger M
Patients who experience venous thromboembolism (VTE) are at important risk for recurrent VTE. When it occurs, recurrent VTE may have serious consequences. Recurrent VTE is fatal in more than 1 in 10 patients if experienced in the first 3 months of therapy and after the initial 3 months of therapy, 1 in 20 episodes of recurrent VTE are fatal. Recurrent VTE leads to significant early morbidity (leg pain, leg swelling, chest pain, shortness of breath), increases the risk of long-term disabling post- thrombotic syndrome[3-5] and chronic thromboembolic pulmonary hypertension This article is protected by copyright. All rights reserved.
PMID: 24845821 [PubMed - as supplied by publisher]